Platelet reactions and immune processes. 3. The inhibition of platelet aggregation by chymotrypsin substrates and inhibitors.
D000596:Amino Acids / Q000494:pharmacology*; D001565:Benzoates / Q000494:pharmacology; D001792:Blood Platelets / Q000276:immunology*; D002918:Chymotrypsin / Q000037:antagonists & inhibitors*; D002934:Cinnamates / Q000494:pharmacology; D003094:Collagen; D003510:Cyclohexanes / Q000494:pharmacology; D004837:Epinephrine; D004950:Esterases; D006636:Histamine Release / Q000187:drug effects*; D006801:Humans; D007546:Isoquinolines / Q000494:pharmacology; D007840:Latex; D008239:Lysine / Q000494:pharmacology; D008863:Microspheres; D010636:Phenols / Q000494:pharmacology; D010648:Phenylacetates / Q000494:pharmacology; D010649:Phenylalanine / Q000494:pharmacology; D010973:Platelet Adhesiveness / Q000517:prevention & control; D011804:Quinolines / Q000494:pharmacology; D014364:Tryptophan / Q000494:pharmacology; D014443:Tyrosine / Q000494:pharmacology
D000596:Amino Acids; D001565:Benzoates; D002934:Cinnamates; D003510:Cyclohexanes; D007546:Isoquinolines; D007840:Latex; D010636:Phenols; D010648:Phenylacetates; D011804:Quinolines; D014443:Tyrosine; D010649:Phenylalanine; D014364:Tryptophan; D003094:Collagen; D004950:Esterases; D002918:Chymotrypsin; D008239:Lysine; D004837:Epinephrine